Literature DB >> 8085920

An electromyographic validation of an abdominal muscle test.

W L Gilleard1, J M Brown.   

Abstract

A recently developed abdominal muscle test (AMT), using four levels of difficulty to assess abdominal muscle strength, was validated by examination of the functional interrelationship between the individual muscles during the AMT, and by determining the relationship between the AMT level of difficulty and electromyographical (EMG) activity. EMG data were collected from the upper and lower rectus abdominis, and the external and internal oblique in 22 subjects as they participated in the AMT. Typically, throughout the AMT, lower rectus abdominis was most active, followed by upper rectus abdominis, external oblique, and internal oblique. EMG activity increased significantly (p < .05) for all muscles from Levels 1 to 3. At Level 4, although upper and lower rectus abdominis remained more active than the obliques, the relative contribution from the obliques was increased. The results of this study show that the AMT is a valid indicator of ability to develop voluntary abdominal muscle tension in Levels 1 to 3, although, Level 4 is more indicative of the oblique muscles' functional abilities and therefore may be considered a distinctly different muscle test.

Entities:  

Mesh:

Year:  1994        PMID: 8085920

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  3 in total

1.  Physiotherapist delivered preparticipation examination: rationale and evidence.

Authors:  Lorrie Maffey; Carolyn Emery
Journal:  N Am J Sports Phys Ther       Date:  2006-11

2.  Abdominal muscle activation: An EMG study of the Sahrmann five-level core stability test.

Authors:  Ebby Waqqash Mohamad Chan; Mohamad Shariff A Hamid; Ali Md Nadzalan; Eliza Hafiz
Journal:  Hong Kong Physiother J       Date:  2020-03-10

3.  The feasibility of measuring the activation of the trunk muscles in healthy older adults during trunk stability exercises.

Authors:  Edwin Y Hanada; Cheryl L Hubley-Kozey; Melissa D McKeon; Sarah A Gordon
Journal:  BMC Geriatr       Date:  2008-12-04       Impact factor: 3.921

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.